Henry Schein (Nasdaq: HSIC ) reported earnings on May 7. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 30 (Q1), Henry Schein beat slightly on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded. Non-GAAP earnings per share grew. GAAP earnings per share grew significantly.
Gross margins contracted, operating margins dropped, net margins increased.
Henry Schein tallied revenue of $2.29 billion. The 12 analysts polled by S&P Capital IQ expected a top line of $2.26 billion on the same basis. GAAP reported sales were 9.3% higher than the prior-year quarter's $2.10 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.06. The 14 earnings estimates compiled by S&P Capital IQ averaged $1.07 per share. Non-GAAP EPS of $1.06 for Q1 were 8.2% higher than the prior-year quarter's $0.98 per share. GAAP EPS of $1.03 for Q1 were 16% higher than the prior-year quarter's $0.89 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 28.2%, 90 basis points worse than the prior-year quarter. Operating margin was 6.7%, 20 basis points worse than the prior-year quarter. Net margin was 4.0%, 20 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $2.38 billion. On the bottom line, the average EPS estimate is $1.23.
Next year's average estimate for revenue is $9.55 billion. The average EPS estimate is $4.90.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 93 members out of 105 rating the stock outperform, and 12 members rating it underperform. Among 32 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 30 give Henry Schein a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Henry Schein is hold, with an average price target of $88.46.
Is Henry Schein the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Henry Schein to My Watchlist.